Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Xolair omalizumab: Phase II started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

TNOX started a placebo-controlled Phase II trial in approximately 150 patients ages 6-75. ......

Inflammation

Xolair omalizumab: Phase II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

East-West Healthcare Reception

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

BioCentury Grand Rounds Inquiry

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home